Dr. Christian Jobin is the Gatorade Trust and Distinguished Professor of Medicine at the University of Florida Gainesville. He received his PhD in Immunology/Microbiology from Université Laval (Quebec, Canada) in 1994 working on the role of 5-Lipoxygenase in rheumatoid arthritis. He completed a post-doctoral fellowship at the University of North Carolina Chapel Hill working on NF-B signalling in inflammatory bowel disease. He is the co-leader of the Immuno-Oncology and Microbiome research program at the University of Florida Health NCI-designated Cancer Institute. Dr. Jobin’s research focuses on establishing the functional impact of microbiota in cancer development and therapeutics. He has published over 230 scientific manuscripts, many appearing in high impact journals (Science, Nature, Nat. Comm., Nat. Micro., Nat. Cancer, Immunity, J. Clin. Invest., J. Exp. Med., Gastroenterology and Gut) and presented his work at various national and international scientific meetings (>265 conferences). His research is supported by different NIH institutes (NCI, NIAID and NIDDK). He holds numerous patents on microbiome-based therapeutics. He is a co-founder of a pharmaceutical company (Bebi Therapeutics) using immuno-stimulatory small molecules derived from human bacteria isolated from human feces to fight cancer.